Compare LEXX & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | AMST |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 6.1M |
| IPO Year | 2011 | 2020 |
| Metric | LEXX | AMST |
|---|---|---|
| Price | $2.86 | $0.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.9K | ★ 76.8K |
| Earning Date | 11-27-2026 | 10-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.83 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $705,923.00 | $364,777.00 |
| Revenue This Year | N/A | $19,089.81 |
| Revenue Next Year | $6,915.00 | $22.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 52.05 | ★ 230.24 |
| 52 Week Low | $0.35 | $0.77 |
| 52 Week High | $21.60 | $3.90 |
| Indicator | LEXX | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 35.35 | 30.63 |
| Support Level | $2.79 | $0.77 |
| Resistance Level | $12.98 | $1.11 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | 0.20 | -0.02 |
| Stochastic Oscillator | 11.57 | 10.10 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.